Stay updated with breaking news from Minor Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN FRANCISCO, CA / ACCESSWIRE / May 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or
91.67% of respondents to a question asking how they see themselves using the product in the future indicated they plan on increasing use of Canalevia®-CA1 over timeCanalevia-CA1, Jaguar Health's FDA Conditionally
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDAIn December 2022, FDA increased the maximum number of dogs that can be treated annually with a
The AHDB board has agreed in principle to transfer up to £1m to the new horticultural company Horticulture Crop Protection (HCP) which was set up…
AHDB has agreed to transfer surplus levy funds to Horticulture Crop Protection Ltd (HCP), set up after a majority of growers voted to end the statutory levy.